REAL-WORLD EVIDENCE OF AUTOMATED INSULIN DELIVERY (AID) USE BY INDIVIDUALS WITH TYPE 2 DIABETES (T2D)

被引:0
|
作者
Fabris, C. [1 ]
Brown, S. [1 ]
Stumpf, M. [1 ]
Kovatchev, B. [1 ]
机构
[1] Univ Virginia, Ctr Diabet Technol, Charlottesville, VA USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
777
引用
收藏
页码:A48 / A48
页数:1
相关论文
共 50 条
  • [31] What Individuals Want to Hear at the Point of Type 2 Diabetes (T2D) Diagnosis
    Boakye, Michelle
    Miyamoto, Sheridan
    Greenwood, Deborah
    NURSING RESEARCH, 2022, 71 (03) : S52 - S52
  • [32] REAL-WORLD ECONOMIC OUTCOMES AMONG PATIENTS WITH TYPE 2 DIABETES (T2D) TREATED WITH DULAGLUTIDE (DU) VS. BASAL INSULIN (BI) IN THE US: THE DISPEL™ STUDY
    Mody, R.
    Huang, Q.
    Yu, M.
    Zhang, X.
    Wang, L.
    Grabner, M.
    Patel, H.
    VALUE IN HEALTH, 2019, 22 : S149 - S150
  • [33] Digital-Tool-Supported Basal Insulin (BI) Titration: Real-World Effectiveness of My Dose Coach (MDC) in People with Type 2 Diabetes (T2D) in Colombia
    Gomez, Ana Maria
    Rincon, Alex Ramirez
    Feriz, Karen
    Salamanca, Carlos F.
    Silva, Liliana P.
    DIABETES, 2022, 71
  • [34] Novel type 2 diabetes (T2D) susceptibility loci and insulin processing and secretion
    Laxgenberg, Claudia
    Loos, Ruth J.
    Elks, Catherine
    Wareham, Nicholas J.
    DIABETES, 2008, 57 : A280 - A280
  • [35] Attitude towards starting insulin therapy in patients with type 2 diabetes (T2D)
    Lee, Lauren J.
    Zagar, Anthony
    Helbers, Lawrence
    Jezorwski, John E.
    Sun, Peter
    Martin, Sherry
    DIABETES, 2008, 57 : A516 - A516
  • [36] use of u200 insulin in automated insulin delivery (AID) systems in adolescents with type 1 diabetes (T1D)
    Chu, P.
    Baker, G.
    Kelly, A.
    Marks, B.
    HORMONE RESEARCH IN PAEDIATRICS, 2024, 97 : 164 - 164
  • [37] Renal Impairment and Antidiabetic Medication Use in Type 2 Diabetes (T2D)
    Koro, Carol E.
    Stender, Monika
    Sowell, Margaret
    Bourgeois, Nancy
    Spain, C. Victor
    DIABETES, 2014, 63 : A636 - A636
  • [38] Evaluation of Treatment Persistence in Individuals with Type 2 Diabetes in a Real-World Setting
    Cefalu, William T.
    Darsow, Tamara
    Petersen, Matt
    Palmer, Liisa
    Thiel, Ellen
    Latts, Lisa
    DIABETES, 2018, 67
  • [39] Initiation of iGlarLixi vs. Basal-Bolus Insulin (BB) in Adults with Type 2 Diabetes (T2D) Advancing from Basal Insulin (BI) Therapy: The SoliComplex Real-World Study
    Pantalone, Kevin M.
    Heller, Caroline
    Lajara, Rosemarie
    Lew, Elisheva
    Li, Xuan
    Dex, Terry A.
    Kilpatrick, Rachel
    DIABETES, 2022, 71
  • [40] Postmarketing Real-World Effectiveness of Hydroxychloroquine (HCQ) in Treatment of Patients with T2D
    Pareek, Anil
    Dharmadhikari, Shruti
    Mehta, Ravi T.
    Naidu, Kumar B.
    DIABETES, 2020, 69